Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules-Reference-Cited by-同舟云学术

Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules

Published:2023-06 Issue:6 Volume:29 Page:799.e1-799.e4
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Grosen Anne Karmisholt,Mikkelsen Susan,Baunwall Simon Mark Dahl,Dahlerup Jens Frederik,Erikstrup Lise Tornvig,Hvas Christian Lodberg,Erikstrup Christian

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT);Baunwall;Scand J Gastroenterol,2021

2. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis;Hooi;Gastroenterology,2017

3. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group;Keller;United Eur Gastroenterol J,2021

4. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China;He;Microb Cell Fact,2021

5. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation;Lai;Aliment Pharmacol Ther,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal microbiota transplantation: current challenges and future landscapes;Clinical Microbiology Reviews;2024-06-13

2. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Journal of Hospital Infection;2024-06

3. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Gut;2024-04-12

4. Helicobacter pylori and oral–gut microbiome: clinical implications;Infection;2023-11-02